super responder tirzepatide Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort Study Tirzepatide - 120mg | PeterMD

We treated the body

Conversely, population studies have found no association between increased risk of diabetic retinopathy and GLP-1 RA use [104, 105], with a low odds ratio observed for exenatide (OR 0.16), liraglutide (OR 0.18), albiglutide (OR 0.09), and dulaglutide (OR 0.11) [106]

Benefits are cumulative with regular treatment

The 10 mg tirzepatide group showed the highest discontinuation rate at 7.1%, but the 15 mg group was actually lower at 6.2%, possibly reflecting that patients who tolerated 10 mg went on to tolerate 15 mg as well

they can help anyone dealing with inflammation, pain, or tissue damage

Some preclinical studies have identified GLP-1 receptors in the intestinal epithelium and immune cells, with animal models suggesting potential anti-inflammatory properties of GLP-1 agonists